683 Capital Management »

Armata Pharmaceuticals shares owned by 683 Capital Management

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $878k 140k 6.28

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Armata Pharmaceuticals

Vanguard Group
683 Capital Management
Geode Capital Management
Edgewood Management
Renaissance Technologies
State Street Corporation
Goldman Sachs Group
Bridgeway Capital Management
SeaCrest Wealth Management
GSB Wealth Management
OMERS Administration Corporation
BlackRock
Northern Trust
Susquehanna International
Qube Research & Technologies

View all funds holding Armata Pharmaceuticals